Risk-reducing surgery for breast and ovarian cancer risks - where are we now? by Hallowell N, Baylock B, Heiniger L, Price M, Butow P

Get full text

Rehabilitating the sick role: post-surgical experiences of high risk women who undergo risk reducing mastectomy by Hallowell N, Heiniger L, Baylock B, Price M, Butow P

Get full text

Prevalence and predictors of insomnia in women with invasive ovarian cancer: anxiety a major factor. by Price, M, Zachariae, R, Butow, P, deFazio, A, Chauhan, D, Espie, C, Friedlander, M, Webb, P

Comparison of group and individual cognitive-behavioral therapy for patients with bulimia nervosa. by Chen, E, Touyz, S, Beumont, P, Fairburn, C, Griffiths, R, Butow, P, Russell, J, Schotte, D, Gertler, R, Basten, C

Interventions before consultations to help patients address their information needs by encouraging question asking: Systematic review by Kinnersley, P, Edwards, A, Hood, K, Prout, H, Cadbury, N, Butler, C, Ryan, R, MacBeth, F, Butow, P

Interventions before consultations to help patients address their information needs by encouraging question asking: systematic review. by Kinnersley, P, Edwards, A, Hood, K, Ryan, R, Prout, H, Cadbury, N, MacBeth, F, Butow, P, Butler, C

Interventions before consultations for helping patients address their information needs. by Kinnersley, P, Edwards, A, Hood, K, Cadbury, N, Ryan, R, Prout, H, Owen, D, Macbeth, F, Butow, P, Butler, C

Interventions before consultations for helping patients address their information needs. by Kinnersley, P, Edwards, A, Hood, K, Cadbury, N, Ryan, R, Prout, H, Owen, D, Macbeth, F, Butow, P, Butler, C

Hope, quality of life, and benefit from treatment in women having chemotherapy for platinum-resistant/refractory recurrent ovarian cancer: the gynecologic cancer intergroup symptom... by Sjoquist, K, Friedlander, M, O'Connell, R, Voysey, M, King, M, Stockler, MR, Oza, A, Gillies, K, Martyn, J, Butow, P

Symptom burden and outcomes of patients with platinum resistant/refractory recurrent ovarian cancer: a reality check: results of stage 1 of the gynecologic cancer intergroup sympto... by Friedlander, M, Stockler, M, O'Connell, R, Voysey, M, Oza, A, Gillies, K, Donovan, H, Martyn, J, Sjoquist, K, Butow, P, King, M

Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian... by King, M, Stockler, MR, Butow, P, O'Connell, R, Voysey, M, Oza, A, Gillies, K, Donovan, H, Mercieca-Bebber, R, Martyn, J, Sjoquist, K, Friedlander, M

Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. by Elwyn, G, O'Connor, A, Stacey, D, Volk, R, Edwards, A, Coulter, A, Thomson, R, Barratt, A, Barry, M, Bernstein, S, Butow, P, Clarke, A, Entwistle, V, Feldman-Stewart, D, Holmes-Rovner, M, Llewellyn-Thomas, H, Moumjid, N, Mulley, A, Ruland, C, Sepucha, K, Sykes, A, Whelan, T

Impact of personal genomic risk information on melanoma prevention behaviors and psychological outcomes: a randomized controlled trial by Smit, AK, Allen, M, Beswick, B, Butow, P, Dawkins, H, Dobbinson, SJ, Dunlop, KL, Espinoza, D, Fenton, G, Kanetsky, PA, Keogh, L, Kimlin, MG, Kirk, J, Law, MH, Lo, S, Low, C, Mann, GJ, Reyes-Marcelino, G, Morton, RL, Newson, AJ, Savard, J, Trevena, L, Wordsworth, S, Cust, AE